Yeah. That's how I read the CEOs comments. Do you know if the materials supplier is only on ELTP? If the FDA wants to push this through to get that supplier approved, that is extremely interesting.
There's a lot of consternation right now over all these drugs being made overseas and suppliers. Also because of the current political landscape.
I read comments here about a potential buyer of the company waiting on the election. The reason I suppose would be the increased value of the company should there be more efforts to bring a lot of this back to the the US.
It's actually a security risk. Regardless of your political affiliation.